Figure 3.
Characteristics of TME and biological function in the cuproptosis subtypes. (A) The abundance of different infiltrating immune cells in the two clusters. (B) GSVA of biological pathways between two distinct subtypes. (C) Prediction of drug responsiveness in the subtypes. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, - P > 0.05. TME, tumor microenvironment; IC50, half maximal inhibitory concentration.
